BRIEF published on 11/20/2025 at 15:34, 3 months 20 days ago Vanguard Group Discloses Position in Spectris plc Form 8.3 Takeover Code Vanguard Group Shareholding Spectris Plc
BRIEF published on 11/20/2025 at 15:34, 3 months 20 days ago Vanguard Group révèle sa participation dans Spectris plc Actionnariat Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Spectris Plc
BRIEF published on 11/20/2025 at 15:32, 3 months 20 days ago The Vanguard Group Discloses Position in Big Yellow Group plc Form 8.3 Takeover Code Vanguard Group Shareholding Disclosure Big Yellow Group
BRIEF published on 11/20/2025 at 15:32, 3 months 20 days ago Le groupe Vanguard révèle sa participation dans Big Yellow Group plc Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Déclaration Relative À L'actionnariat Groupe Big Yellow
BRIEF published on 11/20/2025 at 15:09, 3 months 20 days ago Komax Group Takes Legal Action Over Patent Infringement Legal Proceedings Komax Group Patent Infringement Wire Processing Hacint Intelligence
BRIEF published on 11/20/2025 at 15:09, 3 months 20 days ago Le groupe Komax intente une action en justice pour contrefaçon de brevet. Groupe Komax Violation De Brevet Procédures Judiciaires Traitement Des Fils Hacint Intelligence
BRIEF published on 11/20/2025 at 15:05, 3 months 20 days ago Crofelemer Shows Potential for Expedited Approval in Treating MVID Crofelemer Microvillus Inclusion Disease FDA Approval Clinical Trials Jaguar Health
BRIEF published on 11/20/2025 at 15:05, 3 months 20 days ago Le crofélémer présente un potentiel d'approbation accélérée pour le traitement de la MVID Crofelemer Jaguar Health Essais Cliniques Approbation De La FDA Maladie À Inclusions Microvillositaires
BRIEF published on 11/20/2025 at 15:05, 3 months 20 days ago Revelation Biosciences Advances Toward FDA Meeting on Acute Kidney Injury Treatment Clinical Trial Acute Kidney Injury FDA Meeting Gemini Revelation Biosciences
BRIEF published on 11/20/2025 at 15:05, 3 months 20 days ago Revelation Biosciences progresse vers une réunion avec la FDA sur le traitement des lésions rénales aiguës Essai Clinique Lésion Rénale Aiguë Réunion De La FDA Revelation Biosciences Gémeaux
Published on 03/10/2026 at 14:00, 3 hours 22 minutes ago Updated Lineup Announced for the iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10-11, 2026
Published on 03/10/2026 at 14:00, 3 hours 22 minutes ago Vox Royalty to Participate in the 38th Annual Roth Conference
Published on 03/10/2026 at 13:40, 3 hours 42 minutes ago Nextech3D.ai Reports Strong Start to 2026 With 50 New Customer Contracts Worth $230K, Driving Accelerating Adoption of Its AI Event Technology Platform
Published on 03/10/2026 at 13:30, 3 hours 52 minutes ago Solitario Files Drilling Plan of Operations for Its Bright Angel Gold - Copper Project
Published on 03/10/2026 at 13:00, 4 hours 22 minutes ago Datametrex Integrates AI to Healthcare To Enhance Efficiencies
Published on 03/10/2026 at 15:30, 1 hour 51 minutes ago Skyhawk Therapeutics Appoints Aaron Deves as Chief Commercial Officer to Lead Commercialization of SKY-0515 for Huntington's Disease
Published on 03/10/2026 at 14:45, 2 hours 36 minutes ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc
Published on 03/10/2026 at 14:45, 2 hours 36 minutes ago Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 03/09/2026 at 18:43, 22 hours 38 minutes ago Reporting on share buyback transactions carried out between March 2 and March 6, 2026
Published on 03/09/2026 at 18:43, 22 hours 38 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 2 au 6 mars 2026
Published on 03/09/2026 at 18:21, 23 hours ago TERACT - EN REPONSE A L’OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS ET LES BSAR B DE LA SOCIÉTÉ TERACT
Published on 03/09/2026 at 18:00, 23 hours 22 minutes ago CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 03/09/2026 at 18:00, 23 hours 22 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
